Asahi Songwon (ASAHISONG)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• P/B of 0.98: trading at ₹237.60 below book value of ₹242.24
• Promoter holding at 67% aligns interests with minority shareholders
• Debt/equity of 0.49 is manageable, with no excessive leverage
• Latest quarterly revenue of ₹121 Cr shows a meaningful operating base

Concerns

• Sales growth -9.77% and profit growth -20% show deteriorating operating momentum
• Latest quarter net profit of ₹2 Cr on ₹121 Cr sales implies very thin margins
• Piotroski F-score of 3/9 indicates weak financial health
• ROE of 8.03% and ROCE of 9.17% are subpar; dividend yield is low at 0.67%

AI Analysis

I approach Asahi Songwon as a business, not a ticker. The first thing I notice is the return on capital: 8.03% ROE and 9.17% ROCE. That is mediocre. A truly wonderful business earns far more while employing modest capital. Sales have fallen 9.77% and profits have fallen 20%, and the latest quarter delivered only ₹2 Cr net profit on ₹121 Cr sales. That margin is too thin for comfort. The Piotroski score of 3 out of 9 is another red flag; it suggests financial health is weakening. However, this is not a heavily levered balance sheet. Debt to equity is 0.49, book value is ₹242.24, and the market price is ₹237.60, so I am buying at a slight discount to book. In a cyclical business, a low P/E on depressed earnings can fool you; the right question is what the business can earn in a normal year. The 17.05 P/E tells me little until the cycle turns. Promoter holding is high at 67%, which is good alignment, but the dividend yield of only 0.67% means I am not being paid to wait. There is value in the balance sheet, but the operating trend is going the wrong way. I need to see quarterly sales stabilise, margins recover, and the F-score climb above 5 before I trust this as a meaningful investment. Until then, it is a cyclical candidate and a possible asset-backed bargain, but not a clear compounding machine. I would prefer to wait for evidence of a turn rather than hope for one. In Graham's language, buy with a margin of safety; the price provides some, but the weakening fundamentals reduce that safety. The next few quarters will decide whether this is a value trap or a recovering cyclical.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer